| Derrick Umansky, MD | |
|
131 S Robertson St, #8047, New Orleans, LA 70112-2807 | |
| (504) 988-5565 | |
| Not Available |
| Full Name | Derrick Umansky |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 11 Years |
| Location | 131 S Robertson St, New Orleans, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104168541 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 323885 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tulane Medical Center | New orleans, LA | Hospital |
| Touro Infirmary | New orleans, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern Brain And Spine | 6507867082 | 11 |
News Archive
U.S. residents overall are slightly healthier than they were last year, but the rate of improvement has leveled off since 2000, according to a report released on Tuesday by the UnitedHealth Foundation, the Washington Times reports.
Northwest Biotherapeutics (NASDAQ: NWBO)(NW Bio), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that it has received a decision from the German regulatory agency (the Paul Ehrlich Institute, or PEI) under which the Company's Phase III clinical trial will be able to proceed in Germany after the Company makes three modifications, none of which affect the body of the trial or the bases for seeking product approval.
During the COVID-19 pandemic months of March 2020 to September 2020, U.S. alcohol retail store sales increased compared to usual trends while food services and drinking places sales decreased markedly during the same period, according to a new study at Columbia University Mailman School of Public Health.
Monarch Medical Technologies, the pioneer and leader in mitigating risk associated with drugs and processes of concern in hospitalized patients, today announced the U.S. Food and Drug Administration clearance of its new glucose management solution, EndoTool IV.
New research enhances the current knowledge of how human immunodeficiency virus type-1, which causes AIDS, controls the cell cycle of cells that it infects. The new findings may shed light on how the virus reactivates after entering a dormant state, called latency.
› Verified 8 days ago
| Entity Name | Administrators Of The Tulane Educational Fund |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528014164 PECOS PAC ID: 0446163760 Enrollment ID: O20031201000636 |
News Archive
U.S. residents overall are slightly healthier than they were last year, but the rate of improvement has leveled off since 2000, according to a report released on Tuesday by the UnitedHealth Foundation, the Washington Times reports.
Northwest Biotherapeutics (NASDAQ: NWBO)(NW Bio), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that it has received a decision from the German regulatory agency (the Paul Ehrlich Institute, or PEI) under which the Company's Phase III clinical trial will be able to proceed in Germany after the Company makes three modifications, none of which affect the body of the trial or the bases for seeking product approval.
During the COVID-19 pandemic months of March 2020 to September 2020, U.S. alcohol retail store sales increased compared to usual trends while food services and drinking places sales decreased markedly during the same period, according to a new study at Columbia University Mailman School of Public Health.
Monarch Medical Technologies, the pioneer and leader in mitigating risk associated with drugs and processes of concern in hospitalized patients, today announced the U.S. Food and Drug Administration clearance of its new glucose management solution, EndoTool IV.
New research enhances the current knowledge of how human immunodeficiency virus type-1, which causes AIDS, controls the cell cycle of cells that it infects. The new findings may shed light on how the virus reactivates after entering a dormant state, called latency.
› Verified 8 days ago
| Entity Name | Administrators Of The Tulane Educational Fund |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245434224 PECOS PAC ID: 0446163760 Enrollment ID: O20040114000146 |
News Archive
U.S. residents overall are slightly healthier than they were last year, but the rate of improvement has leveled off since 2000, according to a report released on Tuesday by the UnitedHealth Foundation, the Washington Times reports.
Northwest Biotherapeutics (NASDAQ: NWBO)(NW Bio), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that it has received a decision from the German regulatory agency (the Paul Ehrlich Institute, or PEI) under which the Company's Phase III clinical trial will be able to proceed in Germany after the Company makes three modifications, none of which affect the body of the trial or the bases for seeking product approval.
During the COVID-19 pandemic months of March 2020 to September 2020, U.S. alcohol retail store sales increased compared to usual trends while food services and drinking places sales decreased markedly during the same period, according to a new study at Columbia University Mailman School of Public Health.
Monarch Medical Technologies, the pioneer and leader in mitigating risk associated with drugs and processes of concern in hospitalized patients, today announced the U.S. Food and Drug Administration clearance of its new glucose management solution, EndoTool IV.
New research enhances the current knowledge of how human immunodeficiency virus type-1, which causes AIDS, controls the cell cycle of cells that it infects. The new findings may shed light on how the virus reactivates after entering a dormant state, called latency.
› Verified 8 days ago
| Entity Name | Southern Brain And Spine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801982707 PECOS PAC ID: 6507867082 Enrollment ID: O20070125000563 |
News Archive
U.S. residents overall are slightly healthier than they were last year, but the rate of improvement has leveled off since 2000, according to a report released on Tuesday by the UnitedHealth Foundation, the Washington Times reports.
Northwest Biotherapeutics (NASDAQ: NWBO)(NW Bio), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that it has received a decision from the German regulatory agency (the Paul Ehrlich Institute, or PEI) under which the Company's Phase III clinical trial will be able to proceed in Germany after the Company makes three modifications, none of which affect the body of the trial or the bases for seeking product approval.
During the COVID-19 pandemic months of March 2020 to September 2020, U.S. alcohol retail store sales increased compared to usual trends while food services and drinking places sales decreased markedly during the same period, according to a new study at Columbia University Mailman School of Public Health.
Monarch Medical Technologies, the pioneer and leader in mitigating risk associated with drugs and processes of concern in hospitalized patients, today announced the U.S. Food and Drug Administration clearance of its new glucose management solution, EndoTool IV.
New research enhances the current knowledge of how human immunodeficiency virus type-1, which causes AIDS, controls the cell cycle of cells that it infects. The new findings may shed light on how the virus reactivates after entering a dormant state, called latency.
› Verified 8 days ago
| Entity Name | North Oaks Medical Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972630705 PECOS PAC ID: 2466629522 Enrollment ID: O20120117000359 |
News Archive
U.S. residents overall are slightly healthier than they were last year, but the rate of improvement has leveled off since 2000, according to a report released on Tuesday by the UnitedHealth Foundation, the Washington Times reports.
Northwest Biotherapeutics (NASDAQ: NWBO)(NW Bio), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that it has received a decision from the German regulatory agency (the Paul Ehrlich Institute, or PEI) under which the Company's Phase III clinical trial will be able to proceed in Germany after the Company makes three modifications, none of which affect the body of the trial or the bases for seeking product approval.
During the COVID-19 pandemic months of March 2020 to September 2020, U.S. alcohol retail store sales increased compared to usual trends while food services and drinking places sales decreased markedly during the same period, according to a new study at Columbia University Mailman School of Public Health.
Monarch Medical Technologies, the pioneer and leader in mitigating risk associated with drugs and processes of concern in hospitalized patients, today announced the U.S. Food and Drug Administration clearance of its new glucose management solution, EndoTool IV.
New research enhances the current knowledge of how human immunodeficiency virus type-1, which causes AIDS, controls the cell cycle of cells that it infects. The new findings may shed light on how the virus reactivates after entering a dormant state, called latency.
› Verified 8 days ago
| Entity Name | North Oaks Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427035211 PECOS PAC ID: 9133378870 Enrollment ID: O20121012000490 |
News Archive
U.S. residents overall are slightly healthier than they were last year, but the rate of improvement has leveled off since 2000, according to a report released on Tuesday by the UnitedHealth Foundation, the Washington Times reports.
Northwest Biotherapeutics (NASDAQ: NWBO)(NW Bio), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that it has received a decision from the German regulatory agency (the Paul Ehrlich Institute, or PEI) under which the Company's Phase III clinical trial will be able to proceed in Germany after the Company makes three modifications, none of which affect the body of the trial or the bases for seeking product approval.
During the COVID-19 pandemic months of March 2020 to September 2020, U.S. alcohol retail store sales increased compared to usual trends while food services and drinking places sales decreased markedly during the same period, according to a new study at Columbia University Mailman School of Public Health.
Monarch Medical Technologies, the pioneer and leader in mitigating risk associated with drugs and processes of concern in hospitalized patients, today announced the U.S. Food and Drug Administration clearance of its new glucose management solution, EndoTool IV.
New research enhances the current knowledge of how human immunodeficiency virus type-1, which causes AIDS, controls the cell cycle of cells that it infects. The new findings may shed light on how the virus reactivates after entering a dormant state, called latency.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Derrick Umansky, MD 131 S Robertson St Ste 1300, New Orleans, LA 70112-2807 Ph: (504) 988-3524 | Derrick Umansky, MD 131 S Robertson St, #8047, New Orleans, LA 70112-2807 Ph: (504) 988-5565 |
News Archive
U.S. residents overall are slightly healthier than they were last year, but the rate of improvement has leveled off since 2000, according to a report released on Tuesday by the UnitedHealth Foundation, the Washington Times reports.
Northwest Biotherapeutics (NASDAQ: NWBO)(NW Bio), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that it has received a decision from the German regulatory agency (the Paul Ehrlich Institute, or PEI) under which the Company's Phase III clinical trial will be able to proceed in Germany after the Company makes three modifications, none of which affect the body of the trial or the bases for seeking product approval.
During the COVID-19 pandemic months of March 2020 to September 2020, U.S. alcohol retail store sales increased compared to usual trends while food services and drinking places sales decreased markedly during the same period, according to a new study at Columbia University Mailman School of Public Health.
Monarch Medical Technologies, the pioneer and leader in mitigating risk associated with drugs and processes of concern in hospitalized patients, today announced the U.S. Food and Drug Administration clearance of its new glucose management solution, EndoTool IV.
New research enhances the current knowledge of how human immunodeficiency virus type-1, which causes AIDS, controls the cell cycle of cells that it infects. The new findings may shed light on how the virus reactivates after entering a dormant state, called latency.
› Verified 8 days ago
Robert L Applebaum, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 3434 Prytania St., Suite 230, New Orleans, LA 70115 Phone: 504-340-6976 Fax: 504-349-6786 | |
Pervez Ahmad Khan, MBBS Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1415 Tulane Ave Fl 5, New Orleans, LA 70112 Phone: 504-988-5561 Fax: 504-988-1731 | |
Dr. Aaron S. Dumont, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 131 S Robertson St, Suite 1300, New Orleans, LA 70112 Phone: 504-988-5565 Fax: 504-988-5793 | |
Dr. Olawale A. R. Sulaiman, MD, PHD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1514 Jefferson Highway, New Orleans, LA 70121 Phone: 504-842-4000 | |
Arthur Wang, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1430 Tulane Ave # 8047, New Orleans, LA 70112 Phone: 504-988-3524 | |
Dr. Bradley Joseph Bartholomew, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3629 Prytania St, New Orleans, LA 70115 Phone: 504-895-9544 Fax: 504-895-9548 |